SaBio, Instituto de Investigación en Recursos Cinegéticos IREC-CSIC-UCLM-JCCM, Ciudad Real, Spain.
Department of Veterinary Pathobiology, Center for Veterinary Health Sciences, Oklahoma State University, Stillwater, OK, USA.
Transbound Emerg Dis. 2021 Nov;68(6):3114-3119. doi: 10.1111/tbed.14097. Epub 2021 Apr 20.
Current results do not provide conclusive evidence on the effect of BCG vaccination on COVID-19 alone or in combination with other factors. To address this limitation, in this study we used a citizen science initiative on the COVID-19 pandemic to collect data worldwide during 2 October 2020-30 October 2020 (1,233 individuals) in a structured way for analysing factors and characteristics of affected individuals in relation to BCG vaccination. For the first time, the results of our study suggested that vaccination with BCG may increase the risk for COVID-19 at certain age, particularly in individuals vaccinated at childhood. Childhood BCG vaccination increased the likelihood of being diagnosed with COVID-19 fivefold in COVID-19 low-incidence countries and threefold in high-incidence countries. A reasonable explanation for this effect is the activation of certain innate immunity mechanisms associated with inflammatory reactions. These factors should be considered when analysing the risks associated with this global pandemic.
目前的结果并没有提供关于卡介苗(BCG)疫苗接种对 COVID-19 单独或与其他因素联合作用的确凿证据。为了解决这一局限性,在这项研究中,我们利用 COVID-19 大流行的公民科学倡议,在 2020 年 10 月 2 日至 2020 年 10 月 30 日期间(共 1233 人)以结构化的方式收集了全球数据,以分析与 BCG 疫苗接种相关的受影响个体的因素和特征。我们的研究结果首次表明,BCG 疫苗接种可能会增加某些年龄段 COVID-19 的风险,尤其是在儿童时期接种过 BCG 的人群中。在 COVID-19 低发病率国家,儿童时期的 BCG 疫苗接种使 COVID-19 诊断的可能性增加了五倍,在高发病率国家增加了三倍。这种效应的一个合理解释是与炎症反应相关的某些固有免疫机制的激活。在分析与这一全球大流行相关的风险时,应考虑这些因素。